Managed Care and the Pharmaceutical Industry

Managed Care and the Pharmaceutical Industry

DSpace/Manakin Repository

Managed Care and the Pharmaceutical Industry

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Wickersham, Jaqueline J.	en_US
dc.date.accessioned	2012-06-07T02:05:25Z
dc.date.issued	1995	en_US
dc.identifier.citation	Managed Care and the Pharmaceutical Industry (1995 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846736
dc.description.abstract	The 1992 presidential campaign turned the nation's attention to a number of issues. but none was more controversial than the need for health care reform. As a result of the 1994 election, it appears that President Clinton's proposed health care plan will not gather the support necessary to become law. This does not mean that reforms will fail: it merely means that change will continue as it has for the past ten years. fueled by the people footing the majority of the nation's health costs: employers. As of 1993, employers were paying more than one-third of all medical bills in the United States. This is not to say that government has no role in this metamorphosis. Since state and federal governments employ large numbers of people, they, too, have a significant interest in cost controls. In addition, state and federal governments share the costs of Medicaid, and the federal government is responsible for Medicare.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	HMO	en
dc.subject	PSO	en
dc.subject	PPO	en
dc.subject	health care reform	en
dc.title	Managed Care and the Pharmaceutical Industry	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T02:05:25Z